Bal Pharma Ltd. - Research Center
524824 BALPHARMA Group (B) BSE data
Add to watchlist
| Results | |
| Statement | |
| More |
Ratio
|
Ratios
(Rs crore)
| Mar ' 24 | Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | |
|---|---|---|---|---|---|
| Per share ratios | |||||
| Adjusted EPS (Rs) | 6.50 | 3.90 | 5.79 | 6.14 | -6.28 |
| Adjusted cash EPS (Rs) | 11.85 | 8.67 | 10.67 | 11.03 | -1.32 |
| Reported EPS (Rs) | 6.50 | 3.90 | 5.79 | 6.14 | -6.28 |
| Reported cash EPS (Rs) | 11.85 | 8.67 | 10.67 | 11.03 | -1.32 |
| Dividend per share | 1.20 | 1.00 | 1.00 | 1.00 | - |
| Operating profit per share (Rs) | 20.53 | 16.59 | 15.65 | 17.76 | 4.76 |
| Book value (excl rev res) per share EPS (Rs) | 66.81 | 60.32 | 58.28 | 52.88 | 46.53 |
| Book value (incl rev res) per share EPS (Rs) | 66.81 | 60.32 | 58.28 | 52.88 | 46.53 |
| Net operating income per share EPS (Rs) | 214.21 | 193.18 | 189.15 | 168.20 | 120.43 |
| Free reserves per share EPS (Rs) | - | - | - | - | - |
| Profitability ratios | |||||
| Operating margin (%) | 9.58 | 8.58 | 8.27 | 10.55 | 3.95 |
| Gross profit margin (%) | 7.08 | 6.12 | 5.69 | 7.64 | -0.16 |
| Net profit margin (%) | 3.03 | 2.02 | 3.05 | 3.64 | -5.21 |
| Adjusted cash margin (%) | 5.47 | 4.45 | 5.51 | 6.48 | -1.07 |
| Adjusted return on net worth (%) | 9.72 | 6.47 | 9.93 | 11.60 | -13.49 |
| Reported return on net worth (%) | 9.72 | 6.47 | 9.93 | 11.60 | -13.49 |
| Return on long term funds (%) | 19.26 | 16.54 | 19.80 | 21.26 | 3.74 |
| Leverage ratios | |||||
| Long term debt / Equity | 0.34 | 0.32 | 0.31 | 0.30 | 0.35 |
| Total debt/equity | 1.27 | 1.32 | 1.13 | 1.26 | 1.42 |
| Owners fund as % of total source | 44.10 | 43.04 | 46.84 | 44.19 | 41.29 |
| Fixed assets turnover ratio | 1.47 | 1.49 | 1.54 | 1.48 | 1.02 |
| Liquidity ratios | |||||
| Current ratio | 2.30 | 2.18 | 2.18 | 2.41 | 2.21 |
| Current ratio (inc. st loans) | 0.88 | 0.87 | 0.92 | 0.85 | 0.79 |
| Quick ratio | 1.58 | 1.41 | 1.47 | 1.69 | 1.36 |
| Inventory turnover ratio | 1.41 | 1.38 | 1.52 | 1.41 | 1.07 |
| Payout ratios | |||||
| Dividend payout ratio (net profit) | 15.27 | 25.41 | 17.27 | - | - |
| Dividend payout ratio (cash profit) | 8.37 | 11.44 | 9.37 | - | - |
| Earning retention ratio | 84.73 | 74.59 | 82.73 | 100.00 | 115.92 |
| Cash earnings retention ratio | 91.63 | 88.56 | 90.63 | 100.00 | - |
| Coverage ratios | |||||
| Adjusted cash flow time total debt | 7.15 | 9.20 | 6.20 | 6.05 | - |
| Financial charges coverage ratio | 2.35 | 2.32 | 2.86 | 2.43 | 0.83 |
| Fin. charges cov.ratio (post tax) | 2.23 | 2.12 | 2.52 | 2.37 | 0.84 |
| Component ratios | |||||
| Material cost component (% earnings) | 57.04 | 62.11 | 61.21 | 58.44 | 47.58 |
| Selling cost Component | 0.94 | 0.95 | 0.79 | 0.56 | 1.87 |
| Exports as percent of total sales | 57.59 | 66.65 | 65.48 | 60.33 | 60.61 |
| Import comp. in raw mat. consumed | 38.15 | - | - | 44.00 | 38.75 |
| Long term assets / total Assets | 0.19 | 0.18 | 0.19 | 0.21 | 0.24 |
| Bonus component in equity capital (%) | 19.23 | 19.37 | 20.50 | 20.50 | 21.45 |
© 2025 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis